- Home
- ANGO vs TNYA Comparison
ANGO vs TNYA Comparison
Compare ANGO & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- TNYA
- Stock Information
- Founded
- ANGO 1988
- TNYA 2016
- Country
- ANGO United States
- TNYA United States
- Employees
- ANGO N/A
- TNYA N/A
- Industry
- ANGO Medical/Dental Instruments
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- ANGO Health Care
- TNYA Health Care
- Exchange
- ANGO Nasdaq
- TNYA Nasdaq
- Market Cap
- ANGO 400.8M
- TNYA 326.0M
- IPO Year
- ANGO 2004
- TNYA 2021
- Fundamental
- Price
- ANGO $12.02
- TNYA $1.28
- Analyst Decision
- ANGO Strong Buy
- TNYA Strong Buy
- Analyst Count
- ANGO 3
- TNYA 5
- Target Price
- ANGO $19.33
- TNYA $8.60
- AVG Volume (30 Days)
- ANGO 435.9K
- TNYA 4.5M
- Earning Date
- ANGO 10-02-2025
- TNYA 11-06-2025
- Dividend Yield
- ANGO N/A
- TNYA N/A
- EPS Growth
- ANGO N/A
- TNYA N/A
- EPS
- ANGO N/A
- TNYA N/A
- Revenue
- ANGO $300,718,000.00
- TNYA N/A
- Revenue This Year
- ANGO $8.18
- TNYA N/A
- Revenue Next Year
- ANGO $5.15
- TNYA N/A
- P/E Ratio
- ANGO N/A
- TNYA N/A
- Revenue Growth
- ANGO 2.73
- TNYA N/A
- 52 Week Low
- ANGO $6.63
- TNYA $0.36
- 52 Week High
- ANGO $13.50
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- ANGO 57.09
- TNYA 36.64
- Support Level
- ANGO $11.53
- TNYA $1.37
- Resistance Level
- ANGO $12.18
- TNYA $1.54
- Average True Range (ATR)
- ANGO 0.37
- TNYA 0.14
- MACD
- ANGO -0.07
- TNYA -0.05
- Stochastic Oscillator
- ANGO 48.62
- TNYA 7.43
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.